The Doctoral Network  “Targeting RNA as an approach for treating retinal disease” (RETORNA) aims to treat Retinal Diseases by using RNA therapy.
Among the research objectives, we will study different types of RNA that are expressed in retinal cells. By
observing bioinformatic models, cell and tissue cultures, animal models, and human patients, we will be able to create RNA profiles for different RD. Furthermore, the potential economic and social impact of such strategies upon European countries will be studied, and the possibility of commercialization will be assessed.

RETORNA proposes breakthrough research, distributed in 10 individual projects, performed by 10 Doctoral Candidates (DCs). Some of the most highly qualified European scientists of the field will supervise those DCs, who will be awarded with a PhD at the end of the program. Moreover, DCs will be provided with different transferable skills, necessary for starting successful careers in academia, but also in other areas: industry, public organizations, non-profit organizations,
consultancy, etc.

The RETORNA consortium consists of 8 beneficiaries, including 7 Universities from Spain, Germany, The Netherlands, Türkiye and Ireland and 1 Research Institute  from Italy.

Retorna_EU

Org chart

Teams

Offices